Matthew Ellinwood, DMV, PhD, Chief Scientific Officer at the MPS Society USA, provides an overview of the mucopolysaccharidoses (MPSs) and mucolipidoses (MLs). As Dr. Ellinwood explains, most MPSs are rare genetic conditions that are often difficult to diagnose...
Homology Medicines have received clearance from Health Canada to initiate the juMPStart trial for HMI-203, a one-time, in vivo gene therapy candidate for the treatment of adults with Hunter Syndrome (MPS II). If you are interested in knowing more, join Homology...
The 2022 Canadian MPS Society Annual General Meeting will be held on: Monday 26 September 2022 7:30 pm – 8:30 pm EST (4:30 pm – 5:30 pm PST). The meeting will be held online. Access details will be sent out in a separate email to...
The MPS group is a rare but extraordinary one with Community at our heart. Join our incredible team of Directors in 2022 to help oversee the organisation’s strategic purpose and direction. Your leadership can have a life changing impact on the...
Receiving a diagnosis is difficult for those who love us. In this podcast by Beyond My Battle, two caregivers provide their perspectives on what it felt like. Steve is the parent of a child with Sanfilippo syndrome and Sarah is the parent of a child with Down...
